Medicines for Children

Many medicines, even essential medicines, are not licensed for paediatric use. Often, adult medicines are used in paediatrics; this is “off-label use” as they have not been adequately studied and developed for use in the paediatric population.

Our research and development projects include developing medicines for children with neurological and cardiovascular conditions, to improve their quality of life.

Proveca markets paediatric products in the EU and UK and has partnered with distributors in Eastern Europe and Latin America.

If you’re looking to build a strong business relationship through a trusted partner, Proveca’s team would welcome the opportunity to speak with you.